OPUVIZ
Live / Registered — Registered (as of 05 Aug 2025)
What this means for you
Registered since 05 Aug 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 Aug 2031: the §8 declaration of use).
Record
- Serial number
- 97178356
- Registration number
- 7877368
- Mark type
- Word mark
- Filed
- 17 Dec 2021
- Published for opposition
- 17 Jun 2025
- Registered
- 05 Aug 2025
- Next maintenance filing
- §8 declaration of use, due by 05 Aug 2031 (grace period to 05 Feb 2032)
- Attorney of record
- Douglas A. Rettew
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthalmologic pharmaceutical preparations
Owner
- BIOGEN INTERNATIONAL GMBH, BAAR, CH
- BIOGEN INTERNATIONAL GMBH, BAAR, CH
- Biogen MA Inc., Cambridge, MA
- Biogen MA Inc., Cambridge, MA
Prosecution history
- 05 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 May 2025 — CASE RETURNED TO EXAMINATION
- 28 May 2025 — NOTICE OF ALLOWANCE CANCELLED
- 23 May 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 23 May 2025 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 22 May 2025 — ASSIGNED TO PETITION STAFF
- 21 Apr 2025 — TEAS PETITION TO AMEND BASIS RECEIVED
- 09 Apr 2025 — ASSIGNED TO EXAMINER
- 17 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Oct 2024 — SOU EXTENSION 5 GRANTED
- 17 Oct 2024 — SOU EXTENSION 5 FILED